<DOC>
	<DOC>NCT02181907</DOC>
	<brief_summary>Study to investigate the bioequivalence of UH-AC 62 XX tablets 10 mg (TF4) and UH-AC 62 XX capsules 10 mg by single administration in healthy volunteers.</brief_summary>
	<brief_title>Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Age ≥ 20 and ≤ 35 years Weight : Body Mass Index ≥ 18.5 and &lt; 25 Subjects who are judged by the investigator to be appropriate as the subjects of the study based on results of screening test Subjects who volunteer to participate and are able to fully understand and agree to this study by written informed consent History of gastrointestinal ulcer or surgery of gastrointestinal tract (except appendectomy) History of hypersensitivity to UHAC 62 XX (meloxicam) or salicylate (aspirin etc.) or Nonsteroidal antiinflammatory drugs (NSAIDs) History of aspirin induced asthma (bronchial asthma induced by NSAIDs) A tendency of bleeding History of alcohol or drug abuse Taking an investigational drug within 4 months prior to the trial Whole blood donation more than 400 mL within 3 months prior to the trial Whole blood donation more than 100 mL within 1 month prior to the trial Donation of constituent of blood of more than 400 mL within 1 month prior to the trial Any medication which could influence the results of the trial within 10 days prior to the trial Excessive physical activities within 7 days prior to the trial Alcohol drinking within 3 days prior to the trial History of orthostatic hypotension, fainting spells or blackouts Other than above, those who were judged by the investigator to be inappropriate as the subjects of the study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>